Loading stock data...

Biogen Pharmachem Industries L

BSE: BIOGEN

BSE
0.96 -0.01 (-1.03%)

Prev Close

0.97

Open Price

0.97

Volume

1,141,627

Today Low / High

0.95 / 0.98

52 WK Low / High

0.75 / 1.22

Range

1 - 1

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 0.96, reflecting a change of -0.01 (-1.03093%). The expected target range on the BSE is 1 - 1. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

30 May 0.97 -1.03%
29 May 0.98 -1.02%
28 May 1.00 -2.00%
27 May 1.01 -1.98%
26 May 1.03 -1.94%
23 May 1.04 -0.96%
22 May 0.96 6.25%
21 May 0.97 -1.03%
20 May 0.98 -1.02%
19 May 0.96 -1.04%
16 May 0.91 3.30%
15 May 0.92 -1.09%
14 May 0.91 0.00%
13 May 0.90 1.11%
12 May 0.84 7.14%
09 May 0.84 -1.19%
08 May 0.85 0.00%
07 May 0.76 9.21%
06 May 0.90 -3.33%
05 May 0.89 1.12%

Biogen Pharmachem Industries L Graph

Biogen Pharmachem Industries L Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Biogen Pharmachem Industries L T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 0.96, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 0.96 0.97 0.87 - 1.07
0.98 0.78 - 1.18
0.99 0.69 - 1.29
Bearish Scenario 0.96 0.95 0.86 - 1.05
0.94 0.75 - 1.13
0.93 0.65 - 1.21

Overview of Biogen Pharmachem Industries L

ISIN

INE703D01023

Industry

Investment - Banking & Investment Services

Vol.Avg

993,266

Market Cap

626,498,880

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

-0.07

DCF

1

Financial Ratios Every Investor Needs

Stock Rating Details for BIOGEN

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2024-03-31 1.61 Cr 0.10 Cr 1.51 Cr 0.9408 0.00 Cr 0.01 Cr 1.16 Cr 1.93 Cr 0.03 1.93 Cr 1.2020
2023-03-31 0.67 Cr 0.20 Cr 0.47 Cr 0.7038 0.00 Cr 0.00 Cr 0.46 Cr 0.46 Cr 0.01 0.46 Cr 0.6841
2022-03-31 2.16 Cr 2.08 Cr 0.08 Cr 0.0390 0.00 Cr 0.01 Cr -0.01 Cr -0.01 Cr 0.00 -0.01 Cr -0.0040
2021-03-31 0.01 Cr 1.49 Cr -1.48 Cr -102.2899 0.00 Cr 0.00 Cr -1.60 Cr -1.60 Cr -0.02 -1.60 Cr -110.8017
2020-03-31 0.00 Cr 0.08 Cr -0.08 Cr 313.6272 0.00 Cr 0.00 Cr -0.12 Cr -0.12 Cr 0.00 -0.12 Cr 466.7872

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2024-03-31 0.02 Cr 56.82 Cr 0.30 Cr 56.5204 Cr 0.00 Cr -0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.30 Cr 5.43 Cr 0.3019 Cr
2023-03-31 0.13 Cr 54.83 Cr 0.24 Cr 54.5897 Cr 0.00 Cr -0.13 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.24 Cr 8.85 Cr 0.2381 Cr
2022-03-31 0.08 Cr 54.95 Cr 0.82 Cr 54.1342 Cr 0.00 Cr -0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.82 Cr 6.95 Cr 0.8154 Cr
2021-03-31 0.01 Cr 54.25 Cr 0.11 Cr 54.1428 Cr 0.06 Cr -0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.11 Cr 0.00 Cr 0.1082 Cr
2020-03-31 0.00 Cr 56.09 Cr 0.35 Cr 55.7460 Cr 0.31 Cr 0.30 Cr -56.09 Cr 0.00 Cr 0.00 Cr 0.35 Cr 6.45 Cr 0.6523 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 1.9446 Cr -2.0563 Cr 0.0000 Cr 1.9446 Cr -0.1118 Cr 0.0169 Cr 0.0000 Cr 1.9307 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 1.7045 Cr -1.6589 Cr 0.0000 Cr 1.7044 Cr 0.0456 Cr 0.1287 Cr 0.0000 Cr 0.4555 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 1.3983 Cr -1.3226 Cr 0.0000 Cr 1.3983 Cr 0.0757 Cr 0.0832 Cr 0.0000 Cr -0.0086 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 3.9499 Cr -3.6400 Cr -0.3059 Cr 3.9499 Cr 0.0041 Cr 0.0074 Cr 0.0000 Cr -1.6032 Cr -0.3059 Cr 0.0000 Cr 0.0000 Cr
2020-03-31 -1.2122 Cr 1.5368 Cr -0.3243 Cr -1.2122 Cr 0.0003 Cr 0.0033 Cr 0.0000 Cr -0.1167 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2024-12-31 0.00 Cr 0.05 Cr -0.05 Cr 0.0000 -0.54 Cr -0.31 Cr 0.00 -0.31 Cr 0.0000
2024-09-30 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 -0.35 Cr -1.00 Cr -0.02 -1.00 Cr 0.0000
2024-06-30 -0.09 Cr 0.01 Cr -0.10 Cr 1.1518 -0.16 Cr -0.16 Cr 0.00 -0.16 Cr 1.7415
2024-03-31 0.78 Cr 0.03 Cr 0.75 Cr 0.9670 0.74 Cr 0.74 Cr 0.01 0.74 Cr 0.9514
2023-12-31 0.09 Cr 0.01 Cr 0.08 Cr 0.8983 0.06 Cr 0.06 Cr 0.00 0.06 Cr 0.6742

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2024-09-30 0.06 Cr 0.27 Cr 0.32 Cr 0.08 Cr 0.00 Cr 1.90 Cr 0.00 Cr 55.46 Cr 0.09 Cr
2024-03-31 0.02 Cr 0.01 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.09 Cr 0.00 Cr 56.82 Cr 0.30 Cr
2023-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 0.02 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.41 Cr 0.00 Cr 61.52 Cr 5.80 Cr
2023-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.06 Cr 0.06 Cr 0.00 Cr 0.00 Cr 0.04 Cr 0.06 Cr 0.02 Cr 0.00 Cr 0.06 Cr
2023-09-30 0.72 Cr 0.72 Cr 0.00 Cr 0.00 Cr 0.72 Cr 0.02 Cr -0.70 Cr 0.00 Cr 0.72 Cr
2023-06-30 0.41 Cr 0.41 Cr 0.00 Cr 0.00 Cr 0.28 Cr 0.41 Cr 0.13 Cr 0.00 Cr 0.41 Cr
2023-03-31 -0.20 Cr -0.20 Cr 0.00 Cr 0.00 Cr -0.20 Cr 0.13 Cr 0.33 Cr 0.00 Cr -0.20 Cr
2022-12-31 0.30 Cr 0.30 Cr 0.00 Cr 0.00 Cr 0.28 Cr 0.30 Cr 0.02 Cr 0.00 Cr 0.30 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Investment - Banking & Investment Services

No stocks found in this industry.

Key Executives

Company Secretary
Ms. Khushboo Khandelwal

Gender: female

Year Born:

Chief Financial Officer
Mr. Kelash Bunkar

Gender: male

Year Born: 1996

FAQs about Biogen Pharmachem Industries L

Who is the CEO of the company?

The CEO is Mr. Kelash Bunkar.

What is the current market price of the stock?

The current price is ₹0.96.

What is the 52-week price range?

The range is ₹0.75-1.22.

What is the market capitalization of the company?

The market capitalization is ₹62.65 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -85.93.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Biogen Pharmachem Industries L (ISIN: INE703D01023) is a leading Investment - Banking & Investment Services in India. With a market capitalization of ₹62.65 crores and an average daily volume of 993,266 shares, it operates in the Investment - Banking & Investment Services. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack